Akebia Therapeutics Inc.
AKBA | NASDAQ
$0.97
+$0.03 (+3.36%)
Sep 22, 2026, 12:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 184.84M | 51.87M | 42.93M | 90.47M | 149.8M | 229.09M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | 39.99M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 2.04M |
Other Long-Term Assets | 132.68M | 37.38M | 12.42M | 5.37M | 50.42M | 35.94M |
Receivables | 47.03M | 34.37M | 39.29M | 40.28M | 51.58M | 28.58M |
Inventory | 15.61M | 16.24M | 15.69M | 21.57M | 36.63M | 61.02M |
Other Current Assets | -62.64M | 7.32M | 20.24M | 32.86M | n/a | 12.76M |
Total Current Assets | 184.84M | 113.83M | 118.15M | 185.18M | 271.15M | 371.44M |
Property-Plant & Equipment | n/a | 10.42M | 16.05M | 34.37M | 40.61M | 35.5M |
Goodwill & Intangibles | 59.04M | 59.04M | 95.09M | 131.13M | 167.17M | 199.22M |
Total Long-Term Assets | 191.72M | 106.84M | 123.55M | 170.87M | 258.2M | 272.7M |
Total Assets | 376.57M | 220.67M | 241.7M | 356.05M | 529.35M | 644.14M |
Account Payables | 21.19M | 15.18M | 14.64M | 18.02M | 33.59M | 41.31M |
Deferred Revenue | n/a | n/a | n/a | 3.74M | 20.91M | 53.26M |
Short-Term Debt | 40.08M | 4.31M | 19.55M | 32M | 97.54M | 5.29M |
Other Current Liabilities | 101.67M | 22.75M | 18.26M | 52.53M | 31.18M | 72.89M |
Total Current Liabilities | 162.94M | 80.91M | 99.87M | 129.54M | 261.05M | 187.15M |
Long-Term Debt | 176.21M | 175.47M | 71.2M | 34.08M | 53.08M | 96.38M |
Other Long-Term Liabilities | 4.8M | 9.93M | 48.98M | 114.95M | 86.03M | 63.03M |
Total Long-Term Liabilities | 181.02M | 188.94M | 172.42M | 221.29M | 194.29M | 209.38M |
Total Liabilities | 343.96M | 269.86M | 272.29M | 350.82M | 455.34M | 396.52M |
Total Debt | 216.3M | 188.73M | 104.18M | 99.78M | 189.13M | 126.29M |
Book Value | 32.61M | -49.19M | -30.58M | 5.23M | 74.01M | 247.62M |
Book Value Per Share | 0.13 | -0.23 | -0.16 | 0.03 | 0.45 | 1.79 |
Common Stock | 2K | 2K | 2K | 2K | 1K | 1K |
Retained Earnings | -1.68B | -1.68B | -1.61B | -1.56B | -1.46B | -1.18B |
Comprehensive Income | 6K | 6K | 6K | 6K | 6K | 13K |
Shareholders Equity | 32.61M | -49.19M | -30.58M | 5.23M | 74.01M | 247.62M |
Total Investments | n/a | n/a | n/a | n/a | n/a | 42.03M |
Add to Watchlist
Select watchlists to add or remove AKBA